You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...
Before buying ASX shares, there’s a smarter move investors should make first. Get this wrong, and even great investments can ...
The latest Commonwealth Bank of Australia (ASX: CBA) dividend has just been announced after the release of the FY26 result. CBA revealed that statutory net profit after tax (NPAT) grew by 8% to $10.9 ...
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...
Why is the Core Lithium share price jumping? Investors have been buying the company's shares this morning despite there being no news out of it. However, it is worth highlighting that a number of ASX ...
Pro Medicus Ltd (ASX: PME) secures a 7-year, A$23 million contract with US-based St. Luke’s Health System for its Visage 7 cloud imaging platform.
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...
Bell Potter has maintained its buy rating on Seven shares but increased its 12-month price target to $46. The ASX 300 industrial share is currently trading for $39.95, down 1.53% on Tuesday. Seven ...
Australian Vanadium share price slips as SPP opens to eligible investors The company is aiming to raise $7.5 million but said it could raise more Australian Vanadium's 100% owned subsidiary signed an ...
Amotiv Ltd (ASX: AOV) delivered an unexceptional set of full year results this week, but the Macquarie team still rate the stock a buy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results